These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24685878)

  • 1. Retrospective analysis of fixed drug eruptions among patients attending a tertiary care center in Southern India.
    Pai VV; Kikkeri NN; Athanikar SB; Shukla P; Bhandari P; Rai V
    Indian J Dermatol Venereol Leprol; 2014; 80(2):194. PubMed ID: 24685878
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
    Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
    Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe adverse cutaneous drug eruptions: epidemiological and clinical features.
    Zaraa I; Jones M; Trojjet S; Cheikh Rouhou R; El Euch D; Mokni M; Ben Osman A
    Int J Dermatol; 2011 Jul; 50(7):877-80. PubMed ID: 21699528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year-analysis of fixed drug eruptions in hospital settings in France.
    Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
    Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
    Sharma VK; Sethuraman G; Kumar B
    J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit.
    Campos-Fernández Mdel M; Ponce-De-León-Rosales S; Archer-Dubon C; Orozco-Topete R
    Rev Invest Clin; 2005; 57(6):770-4. PubMed ID: 16708902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985).
    Alanko K; Stubb S; Kauppinen K
    Acta Derm Venereol; 1989; 69(3):223-6. PubMed ID: 2566225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the cutaneous drugs reactions in a teaching hospital in Tunis].
    Souissi A; Fenniche S; Benmously R; Ben Jannet S; Marrak H; Mokhtar I
    Tunis Med; 2007 Dec; 85(12):1011-5. PubMed ID: 19170378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
    Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous drug eruption at hospital in Bamako].
    Konaré HD; Cissé IA; Oumar AA; Idrissa S; Maiga S; Dao S; Rhaly A; Tounkara A
    Mali Med; 2012; 27(1):57-61. PubMed ID: 22766040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult onset Still's disease: experience from a tertiary care rheumatology unit.
    Reddy Munagala VV; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2012 Dec; 15(6):e136-41. PubMed ID: 23253241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is drug allergy less prevalent than previously assumed? A 5-year analysis.
    Heinzerling LM; Tomsitz D; Anliker MD
    Br J Dermatol; 2012 Jan; 166(1):107-14. PubMed ID: 21916887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous adverse drug reactions: an 8-year retrospective study on hospitalized patients in Southern China.
    Wang F; Li Y; Mo Y; Shen C; Yang L; Zhang X
    Indian J Dermatol Venereol Leprol; 2012; 78(4):488-90. PubMed ID: 22772622
    [No Abstract]   [Full Text] [Related]  

  • 17. Trend of syphilis in a tertiary care hospital, New Delhi: 2001-2009.
    Sharma A; Rawat D; Bhalla P
    Indian J Public Health; 2013; 57(2):117-8. PubMed ID: 23873202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug eruptions in children in Cotonou, Benin].
    Adegbidi H; Atadokpede F; Sagbo G; Koudoukpo C; D'Almeida M; Teclessou J; N'Dah P; Djoonyam A Eroume AT; Yedomon HG; Do Ango-Padonou F
    Mali Med; 2012; 27(1):42-6. PubMed ID: 22947321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch testing in fixed drug eruptions--a 20-year review.
    Andrade P; Brinca A; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):195-201. PubMed ID: 21702758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
    Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
    J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.